Supplier
Pharmacy Express INC
Pharmacy Express INC was paid $4K by Medicaid between Nov 2022 and May 2023, across 4 billing codes. Its largest line is 87426, Infectious agent antigen detection, SARS-CoV-2 (COVID-19) — 73% of everything it billed.
33Billing provider infoPHARMACY EXPRESS INC
PATERSON, NJ 07503
PATERSON, NJ 07503
33aNPI1114422102assigned 03/29/2018
33bProvider typePharmacy
28Total paid$4K
24GClaims588
24DCodes billed4
24AFirst – last monthNov 2022 – May 2023
Compared with peers
Next to other Pharmacy providers in New Jersey
Rank by total paid#9 of 57
Median peer was paid$96.00
This provider vs. median44×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 384 | $3K | |
| 2023 | 204 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 73% | 428 | 198 | $3K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 27% | 120 | 101 | $1K |
| K1034 | Provision of covid-19 test, nonprescription self-administered and self-collected use, fda approved, authorized or cleared, one test count | 0% | 16 | 16 | $0.00 |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 24 | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDEMIR, GEMHA (PRESIDENT)